A retrospective chart review conducted after implementing an ERAS program demonstrated that improved patient education led to less use of opioids in the immediate postoperative period.
Approximately one-third of patients in each treatment group experienced symptoms of depression and anxiety during treatment.
Of patients who experienced relapse within 6 months of frontline treatment, 17% achieved a complete response.
Researchers determined that several validated assessment tools are needed to measure health-related quality of life in patients with cutaneous T-cell lymphoma.
Using validated assessment tools, researchers compared patients’ perceptions of HRQOL while undergoing treatment for CML with 1 of 2 TKIs.
Patients with positive interim PET/CT demonstrated poorer overall and progression-free survival compared with patients with negative interim PET/CT.
Over half of patients with TP53-mutated acute myeloid leukemia who received the combination therapy experienced a response.
Researchers did not find a significant difference in survival outcomes for high- and low-risk patients with follicular lymphoma receiving immunotherapy.
A report on oncofertility identifies the optimal multidisciplinary team for assuring that young patients with cancer can preserve their fertility and the options available to them for family building.
An analysis of how functional outcomes are measured in patients with soft tissue sarcoma revealed the efficacy of salvage surgery, and a need to improve frequency of FO measurements.
